tuberculosis: previous and present millennium. tb before advent of chemotherapy tb in 1950 - 2000...
TRANSCRIPT
Tuberculosis: PTuberculosis: Previousrevious and and Present MillenniumPresent Millennium. .
TB before advent of chemotherapy
TB in 1950 - 2000 Morbidity,
Mortality & Elimination of TB.
Censina R. Apap, Pulmonologist.
Introducing MyselfIntroducing Myself
Respiratory specialist since 1983Working in the Netherlands since 1977Special interests include Tuberculosis,
Asthma, COPD, and Oncology.Tuberculosis, a fascinating topic.
Introduction to the lectureIntroduction to the lecture
Natural history of TBMuch morbidity and mortality before the
advent of antibiotics HIV, MDR-TB and relaxation of TB
control programs present new public health problems
TTuberculosis in the past: Phtisisuberculosis in the past: Phtisis
Phtisis renamed Tuberculosis in 1837 Congenital / infectious disease?Known to be infectious in 1865Cause of TB discovered by Koch in 1882 Subdivision: open / closed TB
TB R/ in the pre-antibiotica era.TB R/ in the pre-antibiotica era.
Conservative, directed at relief of symptoms. Sanatorium R/ introduced in Germany by
Brehmer resulted in 25% sputum conversion within 6 mo. 50% of smear positive cases died of disease within 5 years.
How was TB treated in 1937?How was TB treated in 1937?
“Upon the permanence of closure of a tuberculous cavity depends the future development of the disease.The tuberculous cavity is the disease itself, the one feature which controls and regulates the course and outcome of the pulmonary lesion and the fate of the patient.”
Coryllos.
0
200
400
600
800
1000
1200
Total patients
No of deaths
Sanatorium Hospital Home /Total patie 1026 152 347% deaths 55 86 83
Sanatorium Hospital Home R/Total patients 1026 152 347 No of deaths 565 131 288 From W.A. Griep
Deaths (fall off rate) due to TB.Deaths (fall off rate) due to TB.
% of deaths Infectious TB Non-infectious TB
After 1 year 23.8% 0.9%
After 5 years 66.5% 11.2%
After 10 years 74% 16.5%
Active R/ of TB.Active R/ of TB.
Collapse R/ Artificial pneumothorax, Forlanini in
1888; Phrenicus paralysis; Thoracoplasty; Closed suction of lung cavities
(Monaldi);• Lung resection.
Results of active R/- Active treatment gives an additional sputum
conversion of 6%.N.B. Lung resection only possible with required
appropriate intratracheal anaesthetic techniques.
Complications of ThoracoplastyComplications of ThoracoplastyThorax cage instability with paravertebral thoracoplastyEmpyema and wound infections with plombageIn the case of selective thoracoplasty and resection of
first rib: Air emboli Trauma to the brachial plexus and thoracic duct
• Postoperative complications included:• Shock Aspiration pneumonia, atelectasis Cardiac complications
Natural course of TB infectionNatural course of TB infection
Mycobacteria inhaled -> phagocytosis by alveolar macrophages-> 2 possibilities: No infection Infection (early / late)
Transmission of TBTransmission of TB
Source case with open TB of lungs / larynx -> transmission through cough /sneeze ->
infection: early 5-10%, late in 5%.-> result: recovery (possible morbidity) / death. Positive tuberculin test reflects infected
contacts. Progression to early / late infection Possible new source cases provided
Introduction of Antibiotics 1944Introduction of Antibiotics 1944
In 1944, Waksman makes Streptomycin.PAS is available in 1946, INH in 1952 and
Rifampicin in 1965. Improved socio-economic factors and
availability of effective chemotherapy-> radical change in R/
Ambulant and in outpatient setting, unless otherwise indicated.
TB R/ in the antibiotic era.TB R/ in the antibiotic era.
Role of chemotherapy: permanent cure without development of resistance
Lack of success herein due to various factors:
- Improper use of antibiotics- Increased transmission- Priority of disease control less imminent Risk -> outbreak
TerminologyTerminology Rates are expressed per 100,000 inhabitants TB mortality = number of deaths from TBTB lethality = deaths from TB at a certain point of time
expressed as % of incidenceTB prevalence = number of TB cases at a point in timeInfection prevalence = % of population infected with TB TB incidence = number of TB cases infected in a defined
yearInfection incidence = number of new cases (re-) infected
with TB in a certain yearTuberculin index = % of a defined age-group of a
defined population developing a positive tuberculin test at a given point in time
TerminologyTerminology
Bacterial resistance = 1% of TB bacilli population insensitive to chemotherapy
Resistance: mono / multiple INH = 5-10%, RMP rare Resistance: primary / secondary MDR-TB -> resistant to both INH + RMP
Blessing or threat?Blessing or threat?
TB is rare in industrialized countriesIf undetected, increased morbidity followsOutbreak to the general population may be
the result
Current situation in the Current situation in the Netherlands (NL).Netherlands (NL).Mortality rate = 2 / 100,000 Morbidity rate = 20 – 50 / 100,0001n 1987, 1229 cases recordedCurrent problems -> emergence of drug
resistance and HIV-infection.
0%
20%
40%
60%
80%
100%
1981 1984 1987 1990 1994
Total
Immigrants
Dutch
Prognostic factors.Prognostic factors.
Extent of the disease Cavernous lung disease Family history of tuberculosis Social factors Nutrition status Immune state R/
TB in the year 2000TB in the year 2000
TB -> still a leading cause of death in developing countries
TB -> kills 3 million people a year worldwide
3 current epidemics -> HIV, resurgence of TB, MDR-TB
AIDS + MDR-TB (super bug) -> alliance of error
HIV attributable TBHIV attributable TB
In 1990 -> 4%In 2000 -> 14%, of which 40% in sub-
Saharan Africa, another 40% in South East Asia
Global mortality from TB associated with HIV in 1990 -> 116,000
TB in HIV-positive subjectsTB in HIV-positive subjects
M. Tuberculosis: Prevalence is higher than in HIV-
negative subjects; Often preceeds the diagnosis of AIDS,
is commonly a reactivation of a latent infection;
Other mode of presentation than in HIV-negative individuals.
TB variance in HIV + and HIV - subjects.FeaturesAge incidenceFeverCaseationAFB’s
Tuberculin testCalcificationHilaradenopathyCavitationExtrapulmonary
sites
HIV +20 – 50 yearsCommonMinimalPresent, often extracellularNegative in 60%AbsentBilateralRareIn 50%
HIV –50 + yearsCommonPresentPresent, usually intracellularPositive in mostPresentUnilateralCommonRare
Atypical TB in HIV-postives.
Atypical TB: MAIS- complex, exposure difficult to
escape; Late manifestation of HIV disease, an
expression of severe immuno-suppression; Is usually widely disseminated, lung is not
the primary organ affected; Heaps of intracellular AFB’s; Is to be seen as a harbinger of death.
Prevention and control of TBPrevention and control of TB
2 basic strategies of paramount importance: Timely identification and effective
treatment Effective and timely screening of close
contacts
Contact tracingContact tracing
Ring 1 = high contact, 20% risk of infection
Ring 2 = moderate contact, 4% riskRing 3 = little contact, 0,3% riskPositive case finding in an inner ring,
influences testing in an outer ring
Summary (1)Summary (1)
Past R/ ineffective -> high morbidity and mortality
Chemotherapy and improved socio-economic conditions -> a radical change in R/ -> ambulant and in out-patient setting
Result -> TB, a rare disease in industrialized countries
Summary (2)Summary (2)
In 1980+ : relaxation / dismantling of TB control network
HIV epidemic causes TB resurgence Drug resistance leads to MDR-TB in
Sub-Saharan Africa and South East Asia Some states of the USA Might become a problem in W. Europe
A 3rd epidemic with MDR-TB should be avoided at all costs
Recommended literatureRecommended literature
Styblo K. Brudney et al Ryan Fr. Dolin PJ et al Gyselen A.
Recommended sitesRecommended sites
New York’s Health departmentGlobal netwerk TB controlCenters for disease control & preventionJohn Hopkin’s National Institute of Allergy & Infectious
DiseasesTuberculosis testingDiscuss global TB program
Further linksFurther links
Search for TB articles Personal stories, support groups National Library of MedicineWorld Health OrganizationTuberculosis control in NLTuberculosis control in Belgium